Cardiac troponin I elevation and overall survival among cancer patients receiving investigational compounds during phase I trials. Hollebecque, A.; Lanoy, E.; Troallen, F.; Soulat-Dufour, L.; Massard, C.; Bahleda, R.; Varga, A.; Gazzah, A.; Postel-Vinay, S.; Ribrag, V.; Deutsch, E.; Angevin, E.; Boccara, F.; Cohen, A.; Soria, J. C.; Ederhy, S.. Int J Cardiol. 2016; 364-9: p.364-9. doi:10.1016/j.ijcard.2016.04.010 10.1016/j.ijcard.2016.04.010. Epub 2016 Apr 7.Article
Oncostat